EQH Earnings Preview: Analysts Bullish, Corebridge Deal Changes the Calculus

Equitable Holdings reports Q3 results on October 30, carrying a story that extends well beyond the quarterly print: the company's agreed takeover of Corebridge Financial is drawing index tracker attention and reshaping how investors think about the shares.

Options positioning going into the print is mildly more defensive than recent norms, though nowhere near alarming levels. The put/call ratio came in at 0.23 on Monday, fractionally above its 20-day average of 0.21 and just 0.6 standard deviations from the mean. That is a small shift, not a signal of broad anxiety. Short interest reinforces that reading: 2% of free float is borrowed, a genuinely low level, and the borrow market is entirely relaxed, with 270 million shares available relative to fewer than 6 million shorted. Borrowing costs have eased roughly 30% over the past month to 0.42%. The stock itself has barely moved, up about 0.8% on the week against a peer median of around 1.9%, and off 0.5% over the past month, leaving it at $53.58 against a Street mean target of $64.

Analysts are broadly constructive. The recent direction of travel from covering firms has been upward: Wells Fargo lifted its target to $65 in mid-October while keeping its Overweight rating, and Barclays raised its target sharply to $61 from $52 in early October, also maintaining Overweight. Mizuho trimmed slightly, to $66 from $67, but kept its Outperform. The consensus mean of $64 implies roughly 19% upside from current levels, and no firm in the recent changes has cut its rating. The PE ratio of 6.2x sits well below typical financial services multiples, which shapes the bull case: the stock looks cheap on earnings yield relative to the sector. The bear argument centres on balance-sheet complexity. The price/book ratio is deeply negative at minus 9.3x, a feature of life insurer accounting that can obscure economic value but also makes traditional valuation benchmarks harder to interpret.

The most structurally significant fact about EQH heading into the print is the Corebridge acquisition and its index implications. ORTEX forecasts an 84% probability that the deal-driven share count increase triggers a Russell 1000 and Russell 3000 rebalance effective December 31, with an announcement estimated around December 23. An S&P MidCap 400 update carries 80% probability on the same timeline. The MSCI World Small and FTSE Global Small cap indices carry 65% probability of a share-increase adjustment, with an estimated announcement date of December 29. These are ORTEX forecasts, not confirmed events, and the index providers have not yet made announcements. On the ownership side, CRBG moves almost in lockstep with EQH, a 98% correlation over the measured period, so how the market reads the acquisition terms will likely dominate any post-print price action far more than the quarterly data itself.

Insider activity over the past 90 days has been one-directional. Net selling totalled around $5.1 million across multiple directors and a discretionary sale by an executive identified as a senior officer, with the largest single trade a sale of roughly $795,000 in early September. The COO's August trades were all conducted under a 10b5-1 pre-arranged plan, so those carry limited informational weight. The director sales were discretionary. None of these are large relative to the company's $14.6 billion market cap, but the absence of any open-market buying in the period is worth noting.

The October 30 print will test whether Equitable's underlying business momentum, particularly in annuities and asset management, is tracking the bullish analyst consensus at a time when the deal overhang is becoming the dominant lens through which the stock trades.